Since CVID is a lifelong condition, we wanted to explore whether the elevated CXCL13 levels in a patient with CVID remain constantly elevated over time or change with repeated measurements, with the change of CRP, or with medical interventions such as immunoglobulin replacement. This evidence concerns the gene CRP and common variable immunodeficiency.